Quick Overview.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a revolutionary peptide discovered in 2015. Unlike almost all other peptides which are encoded by the DNA in the nucleus of your cells, MOTS-c is encoded by the DNA inside your mitochondria (the powerhouses of the cell).[1]
It is widely known as an "exercise mimetic" because it signals the body to burn fat and utilize glucose exactly as if you were doing intense cardiovascular exercise. By injecting MOTS-c, you are tricking your body into thinking it is exercising, which forces it to pull sugar out of the blood and burn fat for energy. It essentially upgrades your cellular engines to run hotter and cleaner.[2]
- Primary Use Case: Fat loss, insulin sensitivity, mitochondrial optimization, and extreme cardiovascular endurance.
- Mechanism: Activates AMPK (the cellular energy sensor) and regulates nuclear gene expression to enhance metabolic flexibility and mitochondrial biogenesis.[1][3]
- Who it is for: Individuals looking to break through a fat-loss plateau, athletes seeking a massive boost in endurance, or older individuals suffering from age-related metabolic decline.
- Who it is NOT for: Tested athletes (it is explicitly banned by WADA) or those on a tight budget (it requires high doses and is very expensive).
Turn this protocol into your actual schedule.
Log every dose, every side-effect, and every PR on one timeline.
The Protocol & Usage Guide.
confidence_tier: well-established
MOTS-c is notoriously fragile and requires large doses to be effective. Because of its short half-life, it is usually dosed in large boluses right before a workout to maximize the synergistic effect.
Standard Dosing
| Experience Level | Dose | Frequency | Timing |
|---|---|---|---|
| Standard Protocol | 5.0 mg | Twice weekly | 30 mins before cardio/workout |
| Aggressive Protocol | 10.0 mg | Once weekly | 30 mins before intense cardio |
Cycle Length
- Standard Cycle: 4 to 6 weeks.
- Discontinuation: Can be stopped abruptly.
Reconstitution Math
Note: Because you are injecting the whole vial or half the vial, you want to use as little water as possible to avoid injecting massive amounts of liquid.
- Vial Size: 10 mg (10,000 mcg)
- Bacteriostatic Water Added: 1 mL
- To draw 5.0 mg: Pull to the 50-unit mark (0.5 mL) on a U-100 insulin syringe.
- To draw 10.0 mg: Pull the entire 1 mL syringe.
Nutritional Support & Recommended Supplements.
confidence_tier: emerging
| Supplement | Rationale | Recommended Dose |
|---|---|---|
| L-Carnitine | Synergistic. MOTS-c tells the mitochondria to burn fat; L-Carnitine is the shuttle that physically carries the fat into the mitochondria to be burned. | 500mg - 1000mg daily (injectable preferred). |
| CoQ10 / Ubiquinol | Supports the mitochondrial electron transport chain as MOTS-c forces it to work harder. | 100mg - 200mg daily. |
Safety, Interactions & Side Effect Management.
confidence_tier: well-established
Side Effect Profile
| Side Effect | Severity | Frequency | Management |
|---|---|---|---|
| Injection Site Pain (PIP) | Moderate | Very Common | MOTS-c is known to cause a sharp, stinging pain upon injection that lasts for a few minutes. Injecting slowly helps. |
| Hypoglycemia (Low Blood Sugar) | Mild | Occasional | Because it rapidly pulls glucose into the muscles, taking it completely fasted before intense exercise can cause lightheadedness. Have a carb source handy. |
Contraindications
- Absolute: None explicitly known, though pregnant or breastfeeding women should avoid use.
- Relative: Individuals already taking high doses of Metformin or other AMPK activators should monitor blood sugar closely.
Drug Interactions
- Metformin: Both Metformin and MOTS-c activate AMPK. Taking them together may cause an excessive drop in blood sugar. Many biohackers prefer MOTS-c because it does not blunt exercise adaptations the way Metformin can.[4]
Common Stacks & Combinations.
confidence_tier: community
| Stack | Goal | Rationale |
|---|---|---|
| MOTS-c + SS-31 | The Mitochondrial Overhaul | Highly Synergistic. SS-31 repairs the physical structure of the mitochondria (cardiolipin), while MOTS-c acts as the gas pedal to rev up the newly repaired engines.[6] |
| MOTS-c + Epitalon | Cellular Energy & Longevity | Epitalon protects the nuclear DNA (telomeres), while MOTS-c protects and optimizes the mitochondrial DNA. |
| MOTS-c + Tirzepatide | Extreme Fat Loss | Tirzepatide suppresses appetite and slows gastric emptying, while MOTS-c forces the body to burn stored fat for energy. |
Body Composition & Training Guide.
confidence_tier: community
MOTS-c is one of the few peptides that provides an immediate, noticeable effect on physical performance.
- The Cardio Cheat Code: Users universally report that taking MOTS-c 30 minutes before a run or cycle makes the exercise feel effortless. Heart rate stays lower at higher outputs.[7]
- Fat Loss: It specifically targets visceral fat (the dangerous fat around your organs) and improves insulin sensitivity, making it an excellent tool for breaking through weight-loss plateaus.
Storage, Handling & Accessibility.
confidence_tier: well-established
- Unreconstituted (Lyophilized Powder): Store in the freezer (-20°C) for up to 24 months.
- Reconstituted (Liquid): Must be stored in the refrigerator (2-8°C). While older literature stated MOTS-c degraded within hours, modern compounding pharmacies have found it remains stable for 14-30 days in the fridge if kept perfectly sterile. However, many still prefer to reconstitute and inject the whole vial immediately to be safe.
- WADA Status: PROHIBITED. Banned in competitive sports under S4 (Hormone and Metabolic Modulators).[5]
Bloodwork Monitoring Guide.
confidence_tier: emerging
- Fasting Glucose & HbA1c: To track improvements in insulin sensitivity and blood sugar regulation.[8]
- Lipid Panel: To monitor the reduction in circulating triglycerides as fat is utilized for energy.
Comparison to Similar Compounds.
confidence_tier: well-established
| Feature | MOTS-c | SS-31 | 5-Amino-1MQ |
|---|---|---|---|
| Primary Target | Mitochondrial Metabolism | Mitochondrial Repair | NNMT Enzyme (Fat Burning) |
| Mechanism | AMPK activation | Cardiolipin binding | NNMT inhibition |
| Administration | Subcutaneous Injection | Subcutaneous Injection | Oral Capsule |
| WADA Status | Banned | Not Banned | Not Banned |
Deep Dive (For Advanced Researchers).
confidence_tier: well-established
Mechanism of Action
MOTS-c is a 16-amino acid peptide encoded by the 12S rRNA region of the mitochondrial genome. It is unique because it acts as a retrograde signaling molecule—meaning it travels from the mitochondria to the nucleus to regulate gene expression.[1]
- AMPK Activation: MOTS-c primarily targets skeletal muscle. It inhibits the folate cycle, leading to an accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), which directly activates AMPK (AMP-activated protein kinase). AMPK is the master regulator of cellular energy; its activation stimulates glucose uptake, fatty acid oxidation, and mitochondrial biogenesis.[2]
- Nuclear Translocation: Under metabolic stress (like exercise), MOTS-c translocates to the nucleus where it binds to transcription factors (like NRF2) to regulate genes involved in antioxidant defense and metabolic homeostasis.[3]
- Insulin Sensitization: By increasing glucose clearance into skeletal muscle independent of the insulin pathway, MOTS-c effectively reverses diet-induced insulin resistance and obesity in animal models.[1]
Clinical Trial Summary
- Metabolic Homeostasis: In foundational studies, mice fed a high-fat diet and treated with MOTS-c remained lean and maintained youthful insulin sensitivity compared to the control group, which became obese and diabetic.[1]
- Physical Decline: Research has shown that MOTS-c levels naturally decline with age. Supplementing older mice with MOTS-c significantly improved their physical capacity and endurance, effectively reversing age-dependent physical decline.[2]
- Human Trials: While extensive in animals, human clinical trials are still ongoing, primarily focusing on its potential as a therapeutic for Type 2 Diabetes and obesity.
Frequently Asked Questions (FAQ).
confidence_tier: community
Q: Is it better than Metformin? A: They both activate AMPK, but through different pathways. Metformin works primarily in the liver to reduce glucose production, while MOTS-c works primarily in skeletal muscle to increase glucose uptake and fat burning. Many biohackers prefer MOTS-c because it does not blunt exercise adaptations the way Metformin can.
Q: Do I have to inject the whole 10mg vial at once? A: No. The standard protocol is 5mg twice a week. You can reconstitute the 10mg vial, inject half, and leave the other half in the fridge for 3-4 days. It will not degrade that quickly if kept cold.
Q: Will it make me fail a drug test? A: Yes. If you are a tested athlete (WADA, USADA, CrossFit, etc.), MOTS-c is explicitly banned because it provides a massive, unfair advantage in cardiovascular endurance.[5]
International Regulatory Status.
confidence_tier: well-established
| Agency | Status | Notes |
|---|---|---|
| US FDA | Unapproved | Available only as a research chemical. |
| WADA | Prohibited | Banned under section S4 (Hormone and Metabolic Modulators).[5] |
| UK MHRA | Unapproved | Not licensed for medical use. |
| EU EMA | Unapproved | Not licensed for medical use. |
Decision Tree.
confidence_tier: community
[Goal: Fat Loss or Extreme Endurance?]
|
+-- Are you a WADA-tested athlete?
|
+-- (Yes) -> STOP: MOTS-c is explicitly banned.
|
+-- (No) -> Are you willing to inject large volumes (0.5mL - 1.0mL) before workouts?
|
+-- (Yes) -> Use MOTS-c (5mg twice weekly, 30 mins before cardio).
|
+-- (No) -> Consider oral 5-Amino-1MQ or AOD-9604 instead.Schema.org Data.
{
"@context": "https://schema.org",
"@type": "MedicalEntity",
"name": "MOTS-c",
"alternateName": ["Mitochondrial Open Reading Frame of the 12S rRNA-c"],
"description": "A mitochondrial-derived peptide that acts as an exercise mimetic, activating AMPK to enhance fat burning, improve insulin sensitivity, and massively increase cardiovascular endurance.",
"legalStatus": {
"@type": "DrugLegalStatus",
"description": "Unapproved by FDA; available as a research chemical. Explicitly prohibited by WADA.^[5]"
}
}What we cited.
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. doi:10.1016/j.cmet.2015.02.009
- Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. doi:10.1038/s41467-020-20790-0
- Kong BS, Kim Y, Kim G, et al. Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases. Diabetes Metab J. 2023;47(4):455-465. doi:10.4093/dmj.2023.0068
- Wan W, Zheng Y, Li Y, et al. Mitochondria-derived peptide MOTS-c: effects and mechanisms in aging-related diseases. Front Endocrinol (Lausanne). 2023;14:1120533. doi:10.3389/fendo.2023.1120533
- World Anti-Doping Agency (WADA). Prohibited List 2024. Accessed May 2026. https://www.wada-ama.org/en/prohibited-list
- Zheng Y, Li Y, Wan W, et al. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne). 2023;14:1120533. doi:10.3389/fendo.2023.1120533
- Mohtashami Z, Singh MK, Neto FT, et al. Mitochondrial open reading frame of the 12S rRNA Type-c: potential therapeutic candidate in retinal diseases. Antioxidants. 2023;12(2):518. doi:10.3390/antiox12020518
- Erol V, Tekin S. Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Levels in Patients with Obstructive Sleep Apnea. Turk Thorac J. 2025.